GGrantIndex
Sort

17,288 grants matching multiple sclerosis

A Systems Biology Approach for Pediatric and Adult Autoimmune Diseases

$688,030
Maria Virginia Pascual · Baylor Research Institute · U19 · FY2011 · AI

A microfluidic platform for modeling drug transport and cell trafficking across the blood-brain barrier

$687,731
Thomas Neumann · Nortis, Inc. · R44 · FY2017 · NS

Specialization and targeting of CD4+ tissue resident memory T cells in EAE

$687,422
Estelle Bettelli · Benaroya Research Inst At Virginia Mason · R01 · FY2025 · AI

Brain predictors of mobility and falls in older adults with multiple sclerosis

$687,367
Roee Holtzer · Albert Einstein College Of Medicine · R01 · FY2021 · NS

Neuronal Autophagy: a Cell-Autonomous Protection Mechanism

$687,361
Zhenyu Yue · Icahn School Of Medicine At Mount Sinai · R01 · FY2023 · NS

Repurposing Siponimod for Alzheimer's Disease

$687,290
Marwan Noel Sabbagh · St. Joseph'S Hospital And Medical Center · R01 · FY2023 · AG

Peptide and Protein Biomarkers for Amyotrophic Lateral Sclerosis (ALS)

$687,087
Robert P Bowser · St. Joseph'S Hospital And Medical Center · R56 · FY2014 · NS

A Multi-Method Investigation of Cannabis Messaging: Characterizing Source, Content, and Associations with Cannabis Consumption

$687,018
Jane Metrik · Brown University · R01 · FY2024 · DA

Validating Secretory Autophagy as a Therapeutic Strategy for Diverse Forms of ALS and FTD

$686,752
Justin Kawika Ichida · University Of Southern California · R01 · FY2024 · NS

Validating Secretory Autophagy as a Therapeutic Strategy for Diverse Forms of ALS and FTD

$686,752
Justin Kawika Ichida · University Of Southern California · R01 · FY2023 · NS

Embryonic Stem Cell Therapy after Cervical Contusion SCI in NHPs

$686,723
Ephron Solomon Rosenzweig · University Of California, San Diego · R01 · FY2023 · NS

SPEECH MOVEMENT CLASSIFICATION FOR ASSESSING AND TREATING ALS

$686,265
Jordan R Green · Mgh Institute Of Health Professions · R01 · FY2018 · DC

Investigation of the role of ATXN1 in oligodendroglia and neurodegenerative diseases

$686,219
Janghoo Lim · Yale University · R01 · FY2022 · AG

Investigation of the role of ATXN1 in oligodendroglia and neurodegenerative diseases

$686,219
Janghoo Lim · Yale University · R01 · FY2023 · AG

Epigenetic Changes associated with Neurodegenerative Diseases

$685,942
Shelley L Berger · University Of Pennsylvania · R01 · FY2016 · NS

Home-based actigraphy to predict disability progression and enhance clinical trials in multiple sclerosis

$685,681
Ellen M. Mowry · Johns Hopkins University · R01 · FY2021 · NR

Nuclear receptors: action, functions, and roles in disease

$685,660
Anton M Jetten · National Institute Of Environmental Health Sciences · ZIA · FY2015 · ES

Analytical validation of a biochemical test for alpha-synuclein aggregates in biological fluids for the diagnosis of Parkinson's Disease

$685,600
Karen Macleod · Amprion, Inc. · U44 · FY2020 · NS

project 1 - Renewal of the UMDNJ NeuroProteomics Core Facility

$685,558
Hong Li · Univ Of Med/Dent Of Nj-Nj Medical School · P30 · FY2013 · NS

Quantitative MR Imaging and Proton Spectroscopy in MS

$685,462
Robert I. Grossman · New York University School Of Medicine · R01 · FY2008 · NS

MYELIN SULFATIDES ARE NEUROPATHOGENIC TOXINS THAT NEGATIVELY REGULATE NEUROGENESIS IN MULTIPLE SCLEROSIS

$685,434
University Of Illinois · · FY2011 · Department of Defense

Autoimmunity Center of Excellence (ACE) at Stanford

$685,303
Charles Garrison Fathman · Stanford University · U19 · FY2011 · AI

Interrogating a white matter degeneration-specific astrocyte reactivity state and its role in governing repair-associated microglia specification and function.

$685,169
Joshua Evan Burda · Cedars-Sinai Medical Center · R01 · FY2023 · NS

Brain predictors of mobility and falls in older adults with multiple sclerosis

$684,921
Roee Holtzer · Albert Einstein College Of Medicine · R01 · FY2022 · NS

Molecular Mechanisms and Treatment Of Autoimmunity In Man And Animal Models

$684,901
Michael Lenardo · National Institute Of Allergy And Infectious Diseases · Z01 · FY2008 · AI